AtriCure (NASDAQ:ATRC) reported quarterly earnings results on February 17, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.06, beating the consensus estimate of $-0.04 by $0.10 per share. Revenue came in at $140.5M, beating the estimate of $140.1M.
AtriCure's stock moved following the earnings release. The stock currently trades at $31.15 with a market capitalization of $2.1B.
